IJSRP, Volume 5, Issue 7, July 2015 Edition [ISSN 2250-3153]
Christine Faith V. Tan, Maria Korina A. Dakis, Chiara L. Delos Reyes, Dong Yeob Ki, Shannen Jaye O. Langcamon, Denise T. Magdamit, Ma. Jennifer R. Tiburcio, Maria Ruth B. Pineda-Cortel
Adiponectin is an adipocyte-derived peptide that acts as a hormone with anti-inflammatory and insulin-sensitizing properties. Lower serum levels of adiponectin have been consistently associated with increased risk of type 2 diabetes in numerous prospective studies of diverse nationalities. However, few studies among Filipinos were documented. The objective of this study is to identify if adiponectin could serve as a biomarker of type 2 diabetes mellitus among Filipino respondents by determining the association of its levels with the presence of impaired fasting blood glucose, type 2 diabetes mellitus, insulin resistance and other anthropometric parameters. This study, conducted in University of Santo Tomas Hospital-Out Patient Department, compared the levels of adiponectin in normal, pre-diabetic and diabetic groups, with each having 28 randomly selected samples and equivalent gender ratio. Blood samples were analyzed for fasting blood glucose (FBS), insulin and adiponectin.
Christine Faith V. Tan, Maria Korina A. Dakis, Chiara L. Delos Reyes, Dong Yeob Ki, Shannen Jaye O. Langcamon, Denise T. Magdamit, Ma. Jennifer R. Tiburcio, Maria Ruth B. Pineda-Cortel (2018); Adiponectin as a Biomarker of Type 2 Diabetes Mellitus;
Int J Sci Res Publ 5(7) (ISSN: 2250-3153). http://www.ijsrp.org/research-paper-0715.php?rp=P434287